Toxicological considerations for intravitreal drugs

Author： Penha Fernando M   Rodrigues Eduardo B   Furlani Bruno A   Dib Eduardo   Melo Gustavo B   Farah Michel E  

Publisher： Informa Healthcare

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.7, Iss.8, 2011-08, pp. : 1021-1034

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Toxicological considerations for antithyroid drugs in children

By Karras Spiros   Tzotzas Themistoklis   Krassas Gerasimos E  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 4, 2011-04 ,pp. : 399-410

Informa Healthcare

Access to resources Recommend Favorite

Metabolic and toxicological considerations of newly approved prostate cancer drugs

By Tsao Che-Kai   Liaw Bobby   Yee Tiffany   Galsky Matthew D   Oh William K  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 7, 2013-07 ,pp. : 835-846

Informa Healthcare

Access to resources Recommend Favorite

Metabolic and toxicological considerations for the latest drugs used to treat irritable bowel syndrome

By Mozaffari Shilan   Nikfar Shekoufeh   Abdollahi Mohammad  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 4, 2013-04 ,pp. : 403-421

Informa Healthcare

Access to resources Recommend Favorite

The metabolic and toxicological considerations for immunosuppressive drugs used during pancreas transplantation

By Rangel Erika B  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 8, Iss. 12, 2012-12 ,pp. : 1531-1548

Informa Healthcare

Access to resources Recommend Favorite

Metabolic and toxicological considerations of the opioid replacement therapy and analgesic drugs: methadone and buprenorphine

By Moody David E  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 6, 2013-06 ,pp. : 675-697

Informa Healthcare

Access to resources Recommend Favorite